BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23973730)

  • 1. Analysis of clinical and laboratory characteristics in 42 patients with thrombotic thrombocytopenic purpura from a single center in China.
    Deng MY; Zhang GS; Zhang Y; Xiao H; Dai CW; Xu YX; Zheng WL; Peng HL; Shen JK
    Transfus Apher Sci; 2013 Dec; 49(3):447-52. PubMed ID: 23973730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease.
    Delmas Y; Helou S; Chabanier P; Ryman A; Pelluard F; Carles D; Boisseau P; Veyradier A; Horovitz J; Coppo P; Combe C
    BMC Pregnancy Childbirth; 2015 Jun; 15():137. PubMed ID: 26081109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Kremer Hovinga JA; Studt JD; Lämmle B
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):417-21. PubMed ID: 15692254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura.
    Rick ME; Austin H; Leitman SF; Krizek DM; Aronson DL
    Am J Hematol; 2004 Feb; 75(2):96-100. PubMed ID: 14755376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.
    Saha M; McDaniel JK; Zheng XL
    J Thromb Haemost; 2017 Oct; 15(10):1889-1900. PubMed ID: 28662310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
    Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microangiopathic hemolytic anemia and thrombocytopenia. Thrombotic thrombocytopenic purpura].
    Garrido R; Estella Aguado J; Toll T; Alcorta I; Mateo M
    An Esp Pediatr; 2001 Mar; 54(3):313-7. PubMed ID: 11262264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-appendectomy thrombotic thrombocytopenic purpura: a case report and review of the literature.
    Robertson MD; Zumberg M
    Am J Hematol; 2007 Mar; 82(3):224-8. PubMed ID: 17034025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic thrombocytopenic purpura: from platelet aggregates to plasma.
    Marques MB; Mayfield CA; Blackall DP
    Am J Clin Pathol; 2004 Jun; 121 Suppl():S89-96. PubMed ID: 15298154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective review of 25 cases of thrombotic thrombocytopenic purpura in Pakistan.
    Sagheer S; Moiz B; Usman M; Khurshid M
    Ther Apher Dial; 2012 Feb; 16(1):97-103. PubMed ID: 22248203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory.
    Studt JD; Kremer Hovinga JA; Alberio L; Bianchi V; Lämmle B
    Swiss Med Wkly; 2003 Jun; 133(23-24):325-32. PubMed ID: 12923683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activity loss of Von Willebrand factor cleaving protein (ADAMTS-13) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura].
    Hulstein JJ; Rison CN; Kappers-Klunne MC; Hene RJ; Franx A; de Groot PG; Brand A; Fijnheer R
    Ned Tijdschr Geneeskd; 2004 Oct; 148(40):1972-6. PubMed ID: 15524133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic thrombocytopenic purpura without schistocytes on the peripheral blood smear.
    Daram SR; Philipneri M; Puri N; Bastani B
    South Med J; 2005 Mar; 98(3):392-5. PubMed ID: 15813170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel, semi-automated, 60-min-assay to determine von Willebrand factor cleaving activity of ADAMTS-13.
    Kostousov V; Fehr J; Bombeli T
    Thromb Res; 2006; 118(6):723-31. PubMed ID: 16430944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of thrombotic thrombocytopenic purpura].
    Galstyan GM; Klebanova EE
    Ter Arkh; 2020 Dec; 92(12):207-217. PubMed ID: 33720596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of 61 patients with thrombotic thrombocytopenic purpura].
    Shi MJ; Gao WB; Huang WF; Zhu JH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Sep; 53(1):210-214. PubMed ID: 33550359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.
    Böhm M; Betz C; Miesbach W; Krause M; von Auer C; Geiger H; Scharrer I
    Br J Haematol; 2005 Jun; 129(5):644-52. PubMed ID: 15916687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Elliott MA; Nichols WL
    Mayo Clin Proc; 2001 Nov; 76(11):1154-62. PubMed ID: 11702904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.
    Kremer Hovinga JA; Studt JD; Alberio L; Lämmle B
    Semin Hematol; 2004 Jan; 41(1):75-82. PubMed ID: 14727262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of ADAMTS-13 testing in suspected thrombotic microangiopathy: an audit of ADAMTS-13 activity assay requests in routine practice from a tertiary hospital.
    Garizio DG; Wilgen U; Williams BA; Kennedy GA
    Pathology; 2012 Dec; 44(7):638-41. PubMed ID: 23089737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.